Keros Therapeutics (KROS) Free Cash Flow Growth (1y) (2020 - 2025)
Keros Therapeutics (KROS) Free Cash Flow Growth (1y) (2020 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
60.84% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
88.70% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-15.72% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
66.37% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Keros Therapeutics |
399.01 Mn |
111.61 Mn |
- |
44.10% |
| Date | Value |
|---|
| Dec 31, 2025 |
44.10% |
| Sep 30, 2025 |
105.76% |
| Jun 30, 2025 |
26.69% |
| Mar 31, 2025 |
458.58% |
| Dec 31, 2024 |
-78.08% |
| Sep 30, 2024 |
1.87% |
| Jun 30, 2024 |
-23.21% |
| Mar 31, 2024 |
-30.75% |
| Dec 31, 2023 |
-14.68% |
| Sep 30, 2023 |
-32.85% |
| Jun 30, 2023 |
-42.87% |
| Mar 31, 2023 |
-2,162.62% |
| Dec 31, 2022 |
-14.94% |
| Sep 30, 2022 |
-68.59% |
| Jun 30, 2022 |
-22.72% |
| Mar 31, 2022 |
85.59% |
| Dec 31, 2021 |
-144.99% |
| Sep 30, 2021 |
-33.99% |
| Jun 30, 2021 |
-84.40% |
| Mar 31, 2021 |
-26.63% |
